Understanding Coronary Atherosclerosis: Plaque and Biology

Being diagnosed with coronary atherosclerosis can feel overwhelming, but you are part of a very large group of people navigating this condition. In the United States alone, coronary artery disease is the leading cause of death, and global rates remain high ^[1]. However, because it is so common, it is also one of the most extensively researched conditions in modern medicine. We now have a deep understanding of how it works and, more importantly, how to manage it effectively.

Moving Beyond the “Clogged Pipe” Myth

For a long time, atherosclerosis was described like “clogging a pipe”—the idea that fat simply builds up on the inside of your artery until the “drain” is blocked. While the percentage of narrowing (stenosis) remains very important for symptoms and prognosis, we now know the disease is much more complex. Atherosclerosis is actually a dynamic, active inflammatory disease ^[2].

Instead of sitting on top of the artery wall, plaque actually grows inside the wall itself ^[3]. The process begins with endothelial dysfunction, where the delicate inner lining of your blood vessel (the endothelium) becomes “leaky” or irritated ^[2]. This allows cholesterol (specifically LDL) to enter the artery wall, where it becomes “oxidized” and triggers an immune response ^[4]. Your body sends white blood cells to “clean up” the cholesterol, but this creates a cycle of inflammation that causes the plaque to grow and change over time ^[5][6].

Plaque Burden and Vulnerability

Cardiologists today look at both how “narrow” an artery is and the plaque phenotype—or the specific characteristics of the plaque ^[7]. However, routine imaging cannot perfectly label an individual plaque as strictly “safe” or “dangerous.”

• Plaque Composition: Some plaques typically have a thick, tough “cap” made of collagen and smooth muscle cells ^[7]. They often contain significant amounts of calcium. While extensive dense calcification often correlates with more stable plaque, calcification is fundamentally a marker of accumulated plaque burden, and it does not guarantee the plaque won’t cause issues ^[8][9].
• Vulnerable Features: Other plaques are considered “vulnerable,” having a thin, fragile cap and a large “necrotic core” filled with soft fats and inflammatory cells ^[10][11]. These plaques are dangerous because they can rupture—the thin cap breaks open, exposing the “mushy” center to the blood ^[9].

The Danger of Plaque Rupture

When a vulnerable plaque ruptures, it is not just the “narrowing” that causes a heart attack; it is the body’s reaction to the rupture. Your blood sees the exposed plaque as an injury and immediately forms a thrombus (a blood clot) to try to “heal” it ^[12]. This sudden clot can completely block the blood flow in seconds ^[9]. Interestingly, many heart attacks occur in arteries that were only mildly narrowed (less than 50%) before the rupture happened ^[13][11].

Understanding Your Risks and Prevalence

You are certainly not alone in this diagnosis. Recent large-scale imaging studies show just how common this condition is:

• In one imaging study of over 25,000 adults aged 50 to 64, approximately 42% had some form of coronary atherosclerosis visible on a CT scan, even if they had no symptoms ^[14].
• The onset of this disease typically happens about 10 years later in women than in men, but it remains a primary health concern for everyone as they age ^[14][15].
• Even if a coronary artery calcium (CAC) score is zero, a small percentage of people (studies report 5% to 16% depending on the population) may still have “soft” (non-calcified) plaque that requires management ^[16][14].

A Highly Manageable Condition

The most important thing to know is that atherosclerosis is no longer a “waiting game.” Modern medications, like statins and other proven therapies, are specifically designed to reduce cardiovascular events. They do more than just lower cholesterol—they actively reduce the inflammation within the artery wall and help stabilize the disease over time [P-71]^[17]. While tests like high-sensitivity C-reactive protein (hs-CRP) are sometimes used to measure general inflammation in the body, they do not directly measure your coronary plaque activity and are not required for everyone. By treating the underlying biology of the disease, you and your care team can significantly lower the risk of future events.